Controlled release of dexamethasone acetate from biodegradable and biocompatible polyurethane and polyurethane nanocomposite

Journal of Drug Targeting

Volumn 17, Issue 5, 2009, Pages 374-383

  Da Silva, Gisele Rodrigues ^a   Ayres, Eliane ^a   Orefice, Rodrigo Lambert ^a   Moura, Sandra Aparecida L ^a   Cara, Denise Carmona ^a   Da Silva Cunha Jr , Armando ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Dexamethasone acetate; In vitro controlled release; In vivo biocompatibility; Nanocomposite; Polyurethane

Indexed keywords

2,2 BIS(HYDROXYMETHYL)PROPIONIC ACID; CYANIC ACID DERIVATIVE; DEXAMETHASONE ACETATE; ISOPHORONE DIISOCYANATE; MACROGOL DERIVATIVE; MONTMORILLONITE; NANOCOMPOSITE; POLYCAPROLACTONE; POLYURETHAN; PROPIONIC ACID DERIVATIVE; TRIETHYLAMINE; UNCLASSIFIED DRUG; ALUMINUM SILICATE; BIOMATERIAL; DEXAMETHASONE; DRUG DERIVATIVE; PEROXIDASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOCOMPATIBILITY; BIODEGRADABILITY; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; DRUG ABSORPTION; FEMALE; HYDROLYSIS; HYDROPHILICITY; INFLAMMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUBCUTANEOUS TISSUE; ANIMAL; CHEMISTRY; CLAY; DELAYED RELEASE FORMULATION; INFRARED SPECTROSCOPY; MATERIALS TESTING; METABOLISM; NEUTROPHIL; PHYSIOLOGY; RADIATION SCATTERING; SOLUBILITY; X RAY DIFFRACTION;

ALUMINUM SILICATES; ANIMALS; BIOCOMPATIBLE MATERIALS; DELAYED-ACTION PREPARATIONS; DEXAMETHASONE; FEMALE; MATERIALS TESTING; MICE; NANOCOMPOSITES; NEUTROPHILS; PEROXIDASE; POLYURETHANES; SCATTERING, RADIATION; SOLUBILITY; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; X-RAY DIFFRACTION;

EID: 69149109852     PISSN: 1061186X     EISSN: 10292330     Source Type: Journal    
DOI: 10.1080/10611860902839510     Document Type: Article

References (30)

1. Alexandre M, Dubois P. (2000). Polymer-layered silicate nanocomposites: preparation, properties and uses of a new class of materials. Mat Sci Eng, 28, 1-63.
2. Ayres E, Oréfice RL, Yoshida MI. (2007). Phase morphology of hydrolysable polyurethanes derived from aqueous dispersions. Eur Polym J, 43, 3510-3521.
3. Chu B, Hsiao BS. (2001). Small-angle X-ray scattering of polymers. Chem Rev, 101, 1727-1761.
4. Danielsson C, Ruault S, Simonet M, Neuenschwander P, Frey P. (2006). Polyesterurethane foam scaffold for smooth muscle cell tissue engineering. Biomaterials, 27(8), 1410-1415.
5. Einmahl S, Zignani M, Varesio E, Heller J, Veuthey JL, Tabatabay C, Gurny R. (1999). Concomitant and controlled release of dexamethasone and 5-fluorouracil from poly(ortho ester). Int J Pharm, 185, 189-198.
6. Fialho SL, Behar-Cohen F, Silva-Cunha A. (2008). Dexamethasoneloaded poly(å-caprolactone) intravitreal implants: a pilot study. Eur J Pharm Biopharm, 68, 637-646.
7. Garcia CV, Breier AR, Steppe M, Schapoval EES, Oppe TP. (2003). Determination of dexamethasone acetate in cream by HPLC. J Pharm Biomed Anal, 31(3), 597-600.
8. Greenhalgh DG. (1998). The role of apoptosis in wound healing. J Biochem Cell Biol, 30, 1019-1030.
9. Guan J, Sacks MS, Wagner WR. (2004). Biodegradable poly(ether ester urethane) elastomers based on poly(ether ester) triblock copolymers and putrescine: synthesis, characterization and cytocompatibility. Biomaterials, 25, 85-96.
10. Guan J, Fujimoto KL, Sacks MS, Wagner WR. (2005). Preparation and characterization of highly porous, biodegradable scaffolds for soft tissue applications. Biomaterials, 26, 3961-3971.
11. Hayashida K, Kanda K, Yaku H, Ando J, Nakayama Y. (2007). Development of an in vivo tissue-engineered, autologous heart valve (the biovalve): preparation of a prototype model. J Thorac Cardiovasc Surg, 134(1), 152-159.
12. Jiang X, Li J, Ding M, Tan H, Ling Q, Zhong Y, Fu Q. (2007). Synthesis and degradation of nontoxic biodegradable waterborne polyurethanes elastomer with poly(å-caprolactone) and poly(ethylene glycol) as soft segment. Eur Polym J, 43, 1838-1846.
13. Kaplanski G, Marin V, Montero-Julian F, Mantovani A, Farnarier C. (2003). IL-6: a regulator of the transition from neutrophil to monocyte recruitment during inflammation. Trends Immunol, 24(1), 25-29.
14. Kunou N, Ogura Y, Yasukawa T, Kimura H, Miyamoto H, Honda Y, Ikada Y. (2000). Long-term sustained release of ganciclovir from biodegradable scleral implant for the treatment of cytomegalovirus retinitis. J Control Release, 68(2), 263-271.
15. Lee JH, Wee WR, Chung ES, Kim HY, Park SH, Kim YH. (2000). Development of a newly designed double-fixed Seoul-type keratoprosthesis. Arch Ophthalmol, 118(12), 1673-1678.
16. Lee SI, Yu SC, Lee YS. (2001). Degradable polyurethanes containing poly(butylene succinate) and poly(ethylene glycol). Polym Degrad Stab, 72, 81-87.
17. Mahkam M, Sanjani MS. (2003). Preparation of new biodegradable polyurethanes as a therapeutic agent. Polym Degrad Stab, 80, 199-202.
18. Nair LS, Laurencin CT. (2007). Biodegradable polymers as biomaterials. Prog Polym Sci, 32, 762-798.
19. Omar S, Aldosari B, Refai H, Gohary O. (2007). Colon-specific drug delivery for mebeverine hydrochloride. J Drug Target, 15(10), 691-700.
20. Oréfice RL, Ayres E, Pereira MM, Mansur HS. (2005). Using the nanostructure of segmented polyurethanes as a template in the fabrication of nanocomposites. Macromolecules, 38, 4058-4060.
21. Ray SS, Bousmina M. (2005). Biodegradable polymers and their layered silicate nanocomposites: In greening the 21th century materials world. Prog Mat Sci, 50, 962-1079.
22. Santerre JP, Woodhouse K, Laroche G, Labow RS. (2005). Understanding the biodegradation of polyurethanes: from classical implants to tissue engineering materials. Biomaterials, 26, 7457-7470.
23. Smith M, Omidi Y, Gumbleton M. (2007). Primary porcine brain microvascular endothelial cells: biochemical and functional characterisation as a model for drug transport and targeting. J Drug Target, 15(4), 253-258.
24. Smith T, Pearson PA, Blandford DL, Brown JD, Goins KA, Hollins JL, Schmeisser ET, Glavinos P, Baldwin LB, Ashton P. (1992). Intravitreal sustained-release ganciclovir. Arch Ophthalmol, 110, 255-258.
25. Stokes K, Cobian K. (1982). Polyether polyurethanes for implantable pacemaker leads. Biomaterials, 3(4), 225-231.
26. Tatai L, Moore TG, Adhikari R, Malherbe F, Jayasekara R, Griffiths I, Gunatillake PA. (2007). Thermoplastic biodegradable polyurethanes: The effect of chain extender structure on properties and in-vitro degradation. Biomaterials. 28:5407-5417.
27. The United States Pharmacopeia, 31th edition (UPS 31). (2008). United States Pharmacopeial Convention Inc., CD-ROM (Insight Publishing Productivity), Rockville.
28. Wang GB, Labow RS, Santerre JP. (1997). Biodegradation of a poly(ester)urea-urethane by cholesterol esterase: isolation and identification of principal biodegradation products. J Biomed Mater Res, 36, 407-417.
29. Yang T, Chin W, Cherng J, Shau M. (2004). Synthesis of novel biodegradable cationic polymer: N,N-diethylethylenediamine polyurethane as a gene carrier. Biomacromolecules, 5(5), 1926-1932.
30. Zhang C, Zhang N, Wen X. (2007). Synthesis and characterization of biocompatible, degradable, light curable, polyurethane-based elastic hydrogels. J Biomed Mater Res, 82(3), 637-650.